Fremanezumab: all 29 studies that test it
Page 1 of 1. Open to participants first (2), then studies with results posted, then the rest; newest registration first within each.
- Proactively Intervening On Early Cranial Nerve Injury As A Delayed Sequela Of Oropharyngeal Cancer: A Randomized Feasibility Clinical Trial For Pro-Habilitation (proNERVE RCT)Not yet recruitingNCT07832266Phase 1
- Calcitonin Gene-related Peptide Antibody in Acute Mountain SicknessNot yet recruitingNCT07653516Phase 4
- A Randomized, Double-Blind, Placebo-Controlled Study With an Open-Label Period on Efficacy and Safety of Fremanezumab in Chinese Adults With MigraineCompletedNCT05458011Phase 3Results posted
- Real World Effectiveness of Eptinezumab in Participants With MigraineTerminatedNCT05284019Phase 4Results posted
- Fremanezumab, Migraine and SleepTerminatedNCT04693533Phase 4Results posted
- A Trial to Test if Fremanezumab is Effective in Preventing Migraine in Children and AdolescentsCompletedNCT04530110Phase 3Results posted
- A Study to Test if Fremanezumab is Effective in Preventing Chronic Migraine in Participants 6 to 17 Years of AgeCompletedNCT04464707Phase 3Results posted
- Efficacy of AJOVY (Fremanezumab-vfrm) on Interictal Migraine Related BurdenCompletedNCT04461795Phase 4Results posted
- A Study to Test if Fremanezumab is Effective in Preventing Episodic Migraine in Patients 6 to 17 Years of AgeCompletedNCT04458857Phase 3Results posted
- A Study to Evaluate the Efficacy and Safety of Fremanezumab for Preventive Treatment of Migraine in Patients With Major Depressive DisorderCompletedNCT04041284Phase 4Results posted
- A Study to Test the Effectiveness and Safety of Fremanezumab on Participants With FibromyalgiaTerminatedNCT03965091Phase 2Results posted
- A Study to Test if Fremanezumab Reduces Headache in Participants With Posttraumatic Headache (PTH)CompletedNCT03347188Phase 2Results posted
- An Efficacy and Safety Study of Fremanezumab in Adults With MigraineCompletedNCT03308968Phase 3Results posted
- Long-term Safety and Tolerability of Subcutaneous Administration of TEV-48125 for the Preventive Treatment of MigraineCompletedNCT03303105Phase 3Results posted
- Efficacy and Safety of Subcutaneous Administration of TEV-48125 for the Preventive Treatment of Episodic MigraineCompletedNCT03303092Phase 2/3Results posted
- Efficacy and Safety of Subcutaneous Administration of TEV-48125 for the Preventive Treatment of Chronic MigraineCompletedNCT03303079Phase 2/3Results posted
- A Study to Explore the Long-Term Safety and Efficacy of Fremanezumab (TEV-48125) for the Prevention of Cluster HeadacheTerminatedNCT03107052Phase 3Results posted
- A Study Comparing the Efficacy and Safety of Fremanezumab (TEV-48125) for the Prevention of Chronic Cluster Headache (CCH)TerminatedNCT02964338Phase 3Results posted
- A Study to Evaluate the Efficacy and Safety of TEV-48125 (Fremanezumab) for the Prevention of Episodic Cluster Headache (ECH)TerminatedNCT02945046Phase 3Results posted
- Efficacy and Safety of Subcutaneous Administration of Fremanezumab (TEV-48125) for the Preventive Treatment of MigraineCompletedNCT02638103Phase 3Results posted
- Efficacy and Safety of 2 Dose Regimens of TEV-48125 Versus Placebo for the Preventive Treatment of Episodic MigraineCompletedNCT02629861Phase 3Results posted
- Comparing Efficacy and Safety of 2 Dose Regimens of Subcutaneous Administration of TEV-48125 Versus Placebo for the Preventive Treatment of Chronic MigraineCompletedNCT02621931Phase 3Results posted
- A Multicenter Assessment of LBR-101 in High Frequency Episodic MigraineCompletedNCT02025556Phase 2Results posted
- Assessment of LBR-101 In Chronic MigraineCompletedNCT02021773Phase 2Results posted
- Fremanezumab Treatment of Migraine in Women With Menstrual Migraine Ages 18-45CompletedNCT06173661Phase 4
- Medicinal vs. Orthotic Comparison for Migraine Prevention: A Double-Blind StudyStatus unknownNCT04547179Not applicable
- A Study to Test if Fremanezumab Reduces Pain in Patients With Interstitial Cystitis-Bladder Pain SyndromeWithdrawnNCT04447729Phase 2
- Safety and Efficacy of Fremanezumab for Migraine in Adult CADASILWithdrawnNCT04334408Phase 2
- Safety and Bioavailability of IV and SC LBR-101CompletedNCT01991509Phase 1